# Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ

> **NCT03025724** · NA · UNKNOWN · sponsor: **Rhode Island Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Levulan Kerastick
- **DEVICE:** blue light source
- **OTHER:** participant satisfaction survey

## Key facts

- **NCT ID:** NCT03025724
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03025724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03025724, "Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03025724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*